Re:Compass Pathways' Phase IIb psilocybin trial shows reduce...
by drooby on Tuesday November 09, 2021 @09:27PM
(#29170395)
I’m not sure if it makes a difference, but this study was conducted on _treatment resistant_ patients.
[ Parent
| on HN ]
There are no comments on this comment yet.